Sung-Hak Kim found that MLK4 is overexpressed in mesenchymal (MES) glioma stem cells and its knockdown suppresses tumorigenesis, self-renewal, motility, and radioresistance. The gene discussed is MAP3K21; the disease is central nervous system cancer.